Brian Eisner is the Co-Director of the Kidney Stone Program at the MGH. He specializes in kidney stone surgery, kidney stone prevention and related research.
- Centers & Specialties
- Clinical Interests
- Kidney stone disease
- Bladder stones
- Kidney stone surgery
- Kidney stone prevention
- Shock wave lithotripsy
- Percutaneous nephrolithotomy
- Ureteropelvic junction obstruction
- Laparoscopic / Minimally invasive surgery
- Medical Education
- MD, University of Michigan Medical School
- Residency, Massachusetts General Hospital
- Fellowship, UC San Francisco
- Board Certifications
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Medicare - ACD
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Adult and Pediatric
- Provider Gender
Dr. Brian Eisner is the Co-Director of the Kidney Stone Program at the MGH. He specializes in kidney stone surgery, kidney stone prevention and related research.
Dr. Eisner was born in Miami, FL and attended Harvard College and the University of Michigan Medical School. He completed urology residency training at Massachusetts General Hospital and a fellowship in endourology and urinary stone disease at the University of California, San Francisco. His clinical practice focuses on kidney stone prevention, minimally invasive and surgical treatments for kidney stones, and laparoscopic surgery. He is actively involved in research involving kidney stone prevention, risk factors for kidney stone disease and surgical treatment of kidney stones.
- Research Summary
Dr. Eisner's research interests include prevention of kidney stone disease, risk factors for kidney stone disease, surgical treatment for kidney stones, and radiology of the urinary tract.
- Eisner BH, Asplin JA, Goldfarb DS, Ahmad A, Stoller ML. Citrate, malate, and alkali concentrations in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol (in press)
- Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone-formers excrete more oxalate and have lower urine pH than non-diabetic stone formers. J Urol (in press)
- Eisner BH, Porten SP, Bechis SK, Stoller ML. The Role of Race in Determining 24-Hour Urine Composition in White and Asian/Pacific Islander Stone Formers. J Urol. 2010;183(4):1407-1411.
- Eisner BH, Porten SP, Bechis SK, Stoller ML. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol. 2010;183(2):576-9.
- Chi T, Eisner BH, Berger AD, Stoller ML. An ex-vivo evaluation of the application and strength of a novel laparoscopic knot substitute device. J Endourol. 2010;24(1):95-8.
- Eisner BH, Eisenberg ML, Stoller ML. Relationship Between Body Mass Index and Quantitative 24-Hour Urine Chemistries in Patients With Nephrolithiasis. Urology. 2009.
Dusting, a new protocol for treating kidney stones using recent laser technologies, has proven to deliver successful patient outcomes equal to those of traditional basketing, according to a study by the Endourology Disease Group for Excellence.
165 Cambridge St
Boston, MA 02114